<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03054818</url>
  </required_header>
  <id_info>
    <org_study_id>RG01N-1578-1.0</org_study_id>
    <nct_id>NCT03054818</nct_id>
  </id_info>
  <brief_title>Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）</brief_title>
  <official_title>Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu Kanghong Biotech Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chengdu Kanghong Biotech Co.,Ltd.</source>
  <brief_summary>
    <textblock>
      This is a post-marketing drug safety monitoring study in a prospective manner, and data
      collection will be performed in a registration-follow-up manner. Safety information about
      patients who have received intravitreal injection of Conbercept Ophthalmic Injection in
      medical institutions involved in the study during research will be actively monitored without
      intervening in diagnosis and treatment. All patients enrolled will be followed up for one
      year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>New Adverse Reactions</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the type, incidence and severity of new adverse reactions in patients who have received intravitreal injection of Conbercept Ophthalmic Injection during the study;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Common Ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the type, incidence and severity of common ocular adverse events in patients who have received intravitreal injection of Conbercept Ophthalmic Injection during the study, including: 1) bleeding at injection site; 2) increased intraocular pressure (IOP); 3) conjunctival congestion; 4) conjunctivitis; 5) decreased visual sensitivity; and 6) muscae volitantes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Common Ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the Common Ocular AEs' correlation with Conbercept Ophthalmic Injection therapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other Ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the type, incidence and severity of other ocular adverse events in patients who have received intravitreal injection of Conbercept Ophthalmic Injection during the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the Other Ocular AEs' correlation with Conbercept Ophthalmic Injection therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the type, incidence and severity of non-ocular adverse events during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-ocular Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the Non-ocular AEs' correlation with Conbercept Ophthalmic Injection therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events of Special Interest(AESI)</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the incidence and severity of adverse events of special interest (AESI) during the study, including: 1) retinal detachment; 2) retinal tears; 3) retinal pigment epithelial detachment; 4) retinal pigment epithelium tears; 5) geographic atrophy; 6) endophthalmitis; 7) arterial thromboembolic events (ATEs); and 8) hypertension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events of Special Interest(AESI)</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the AESI's correlation with Conbercept Ophthalmic Injection therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAE</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the type, incidence and severity of all severe adverse events during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAE</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the SAEs' correlation with Conbercept Ophthalmic Injection therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events Related to Intravitreal Injection Practices</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the incidence and severity of possible adverse events related to intravitreal injection practices of Conbercept Ophthalmic Injection during the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events of Special Population</measure>
    <time_frame>1 year</time_frame>
    <description>To observe the incidence and severity of adverse events of special population during the study,including children and adolescents (aged under 18), and pregnant women.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events of Special Population</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the AEs' correlation with Conbercept Ophthalmic Injection therapy.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Wet Age-related Macular Degeneration (wAMD)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All medical academies will initially identify whether patients are enrolled based on
        baseline registration information.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The condition that informed consent has been freely given prior to research-related
             procedures;

          2. Patients who have received at least one intravitreal injection of Conbercept
             Ophthalmic Injection after informed consent has been given.

        Exclusion Criteria:

          1. Patients who have been on any of other anti-VEGF drugs systematically or locally,
             including but not limited to bevacizumab, ranibizumab and aflibercept, 90 days before
             enrollment;

          2. Those who are on other study drugs or have been on other study drugs 30 before
             informed consent is given.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ningli Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>BEIJING TONGREN HOSPITAL, CMU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ningli Wang</last_name>
    <phone>010-58265922</phone>
    <email>wningli@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Baoji People'S Hospital</name>
      <address>
        <city>Baoji</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wuqiang Shan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Aier-Intech Eye Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Gu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Tongren Hospital, Cmu</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenbin Wei</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eye Hospital, China Academy of Chinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hong Qing</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Zhong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongliang Dou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The 306Th Hospital of Pla</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ling Luo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xuanwu Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dachuan Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jie Zhong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiyuan Zhou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiang Ma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The third people's Hospital of Dalian</name>
      <address>
        <city>Dalian</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhongming Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiangyin Sha</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Guizhou Medical University</name>
      <address>
        <city>Guiyang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xian Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of ZhejiangUniversity School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ke Yao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anhui Provincial Hospital</name>
      <address>
        <city>Hefei</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gengjie Ke</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>JOINT SHANTOU INTERNATIONAL EYE CENTER of Shantou University and The Chinese University of Hong Kong</name>
      <address>
        <city>Hongkong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haoyu Cheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Eye Hospital</name>
      <address>
        <city>Jilan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gongqiang Yuan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincal Hospital</name>
      <address>
        <city>Jilan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bojun Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Jilin University</name>
      <address>
        <city>Jiling</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guanfang Shu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kashgar First People's Hospital</name>
      <address>
        <city>Kashi</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ruixing Ding</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lanzhou University Second Hospital</name>
      <address>
        <city>Lanzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenfang Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Hospital of Mudanjiang Forestry</name>
      <address>
        <city>Mudanjiang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuqing Zhu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital of CTM</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wei Wei</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The People'S Hospital of Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Nanning</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Siming Zheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo Eye Hospital</name>
      <address>
        <city>Ningbo</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianshu Yuan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningxia People'S Hospital</name>
      <address>
        <city>Ningxia</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xunlun Sheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pingdingshan People'S Hospital No.1</name>
      <address>
        <city>Pingdingshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Qiqihar</name>
      <address>
        <city>Qiqihar</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hang Lu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rui Jin Hospital Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xi Sheng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Baoshan Hospital of Integrate Traditional Chinese and Western Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianming Tang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai General Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuqing Yu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Tongji Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ao Rong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenyang the Fourth Hospital of People</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hailing Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Fourth Affiliated Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fan Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianhong Huang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenzhen Eye Hospital</name>
      <address>
        <city>Shenzhen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qingshan Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jingxue Ma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanxi Eye Hospital</name>
      <address>
        <city>Taiyuan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yading Jia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University Eye Hospital</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaorong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wuhan General Hospital of Pla</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanping Song</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>No.474 Hospital of Pla</name>
      <address>
        <city>Wulumuqi</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaowei Gao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wuxi NO.2 People's Hospital</name>
      <address>
        <city>Wuxi</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhifeng Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hong Yan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xi'An No.4 Hospitla</name>
      <address>
        <city>Xi'an</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunning Lei</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xian</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yusheng Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hebeisheng Eye Hospital</name>
      <address>
        <city>Xingtai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Minglian Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Xuzhou</name>
      <address>
        <city>Xuzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suyan Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yay-Sen University</name>
      <address>
        <city>Zhongshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoling Liang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2017</study_first_posted>
  <last_update_submitted>February 13, 2017</last_update_submitted>
  <last_update_submitted_qc>February 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

